麻醉氣體市場：按產品類型、麻醉氣體、最終用戶、地區 - 規模、份額、展望、機會分析，2022-2028 年

稱為吸入麻醉藥（例如，異氟烷、七氟烷、地氟烷、氟烷、一氧化二氮）的麻醉氣體是術前鎮靜和圍手術期靜脈麻醉劑（例如咪達唑侖、異丙酚）的輔助麻醉。作為主要維持療法使用。

市場動態

在預測期內，慢性病患病率增加、老年（老年人）人口增加、麻醉氣體需求增加、手術期間麻醉使用增加、全球外科手術數量增加。是預計將推動麻醉氣體市場增長的主要因素。

例如，2022 年 2 月，Sedana Medical 宣佈在德國推出 Sedaconda（異氟醚）。 Sedaconda（異氟醚）通過醫療設備 Sedaconda ACD（麻醉保護裝置）輸送，是唯一獲准用於重症監護的吸入鎮靜療法。 Sedaconda 於 2021 年 7 月獲得歐洲 DCP 批准。

這項研究的主要特點

• 本報告對全球麻醉氣體市場進行了深入分析，提供了以 2021 年為基準年的預測期 (2022-2028) 的市場規模和復合年增長率 (CAGR%)。.
• 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
• 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
• 它根據以下參數介紹了全球麻醉氣體市場的主要參與者，包括公司亮點、產品組合、主要亮點、財務業績和戰略。
• 本研究涵蓋的主要公司包括百特、艾伯維公司、Piramal Enterprises Ltd.、Fresenius SE & Co. KgaA、Dragerwerk AG & Co. KgaA、GE Healthcare 和 Mindray Medical International Limited。等等。
• 這份報告中的見解將使營銷人員和企業高管能夠就他們未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 《全球麻醉氣體市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球麻醉氣體市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 按產品類型劃分的市場概況
  • 麻醉氣體市場概況
  • 市場概況：按最終用戶分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 麻醉氣體的需求和使用量增加
  • 麻醉氣體的副作用
  • 手術次數增加
• 影響分析
• 主要亮點
• 監管情景
• 產品發布和批准
• 害蟲分析
• 對 PORTER 的分析
• 合併/收購場景

第 4 章全球麻醉氣體市場 - 冠狀病毒 (COVID-19) 大流行的影響

• COVID-19 的流行病學特徵
• 供應方和需求方分析
• 經濟影響

第 5 章按產品類型分列的全球麻醉氣體市場，2017-2028

• 麻醉氣體
• 汽化器裝置

第 6 章。全球麻醉氣體市場，按麻醉氣體分類，2017-2028

• 地氟醚
• 七氟醚
• 異氟醚
• 一氧化二氮
• 其他麻醉氣體

第 7 章全球麻醉氣體市場：按最終用戶分類，2017-2028

• 醫院
• 門診手術中心

第 8 章按地區分列的全球麻醉氣體市場，2017-2028

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲
• 世界其他地方

第9章競爭格局

• Baxter
• AbbVie Inc.
• Piramal Enterprises Ltd.
• Fresenius SE & Co. KgaA
• Dragerwerk AG & Co. KgaA
• GE Healthcare
• Mindray Medical International Limited

第 10 章

• 調查方法介紹
• 關於出版商

Anesthetic gases (isoflurane, sevoflurane, desflurane, halothane, and nitrous oxide, among others), also known as inhaled anesthetics, are administered as a primary therapy for preoperative sedation and adjunctive anesthesia maintenance to intravenous (IV) anesthetic agents (such as midazolam and propofol) in the perioperative setting.

Market Dynamics:

Increase in prevalence of chronic diseases, increase in geriatric (aging) population, rise in demand for anesthesia gases, increase in use of anesthesia during surgeries, and rise in number of surgical procedures around the world are major factors expected to propel growth of the global anesthesia gases market during the forecast period.

For instance, in February 2022, Sedana Medical announced the launch of Sedaconda (isoflurane) in Germany. Sedaconda (isoflurane), delivered via medical device Sedaconda ACD (Anaesthetic Conserving Device), is the only approved inhaled sedation therapy for use during intensive care. Sedaconda received European DCP approval in July 2021.

Key features of the study:

• This report provides in-depth analysis of the global anesthesia gases market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global anesthesia gases market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Baxter, AbbVie Inc., Piramal Enterprises Ltd., Fresenius SE & Co. KgaA, Dragerwerk AG & Co. KgaA, GE Healthcare, and Mindray Medical International Limited, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global anesthesia gases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anesthesia gases market.

Detailed Segmentation:

• Global Anesthesia Gases Market, By Product Type:
  • Anesthesia Gases
  • Vaporizer Devices
• Global Anesthesia Gases Market, By Anesthesia Gases:
  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Nitrous Oxide
  • Other Anesthesia Gases
• Global Anesthesia Gases Market, By End User:
  • Hospital
  • Ambulatory Surgical Centers
• Global Anesthesia Gases Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Baxter
  • AbbVie Inc.
  • Piramal Enterprises Ltd.
  • Fresenius SE & Co. KgaA
  • Dragerwerk AG & Co. KgaA
  • GE Healthcare
  • Mindray Medical International Limited

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Anesthesia Gases
  • Market Snapshot, By End User
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increase in demand for or use of anesthesia gases
  • Side effects of anesthesia gases
  • Increase in number of surgical procedures
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Anesthesia Gases Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Anesthesia Gases Market, By Product Type, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Anesthesia Gases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Vaporizer Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Anesthesia Gases Market, By Anesthesia Gases, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Desflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Sevoflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Isoflurane
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Nitrous Oxide
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Other Anesthesia Gases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Anesthesia Gases Market, By End User, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospital
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Global Anesthesia Gases Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

9. Competitive Landscape

• Baxter
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Piramal Enterprises Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fresenius SE & Co. KgaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dragerwerk AG & Co. KgaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mindray Medical International Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us